Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nu.Q® NETs immunoassay detects Neutrophil Extracellular Traps by quantifying circulating H3.1 nucleosomes

Thursday, September 19, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The Nu.Q® NETs immunoassay was presented at Neutrophil 2024, showcasing its ability to detect Neutrophil Extracellular Traps by quantifying circulating H3.1 nucleosomes. This innovative approach could significantly improve cancer diagnostics and prognostic assessments. Related articles indicate ongoing research into the prognostic value of the Nu.Q® Cancer Test.
Price reaction · baseline $12.284 (2024-09-18 close) · hit pre-market · 1 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
+3.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • The Nu.Q® NETs immunoassay shows promise in detecting Neutrophil Extracellular Traps.
  • Quantifying circulating H3.1 nucleosomes may enhance cancer diagnostics.
  • The presentation at Neutrophil 2024 highlights innovative research in immunoassays.

Full Press Release Details

Poster titled: Nu.Q® NETs immunoassay detects Neutrophil Extracellular Traps by quantifying circulating H3.1 nucleosomes.
Presented at: Neutrophil 2024
Wargnies et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What does the Nu.Q® NETs immunoassay detect?

It detects Neutrophil Extracellular Traps by quantifying circulating H3.1 nucleosomes.

Where was the Nu.Q® NETs immunoassay presented?

It was presented at the Neutrophil 2024 conference.

What is the significance of H3.1 nucleosomes?

Quantifying H3.1 nucleosomes may enhance the detection and prognosis of cancer.

Who conducted the research on the Nu.Q® NETs immunoassay?

The research was conducted by Wargnies et al.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Neutrophil Extracellular Traps H3.1 nucleosomes cancer diagnostics immunoassay
Last updated: Sep 19, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk